HROW
Harrow, Inc. - Common Stock (HROW)
$92
About Harrow, Inc. - Common Stock (HROW)
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.
Details
Daily high
$34.30
Daily low
$32.64
Price at open
$33.21
52 Week High
$54.85
52 Week Low
$28.54
Market cap
1.2B
Dividend yield
-
Volume
611,427
Avg. volume
557,551
P/E ratio
-33.10
Harrow, Inc. - Common Stock News
Details
Daily high
$34.30
Daily low
$32.64
Price at open
$33.21
52 Week High
$54.85
52 Week Low
$28.54
Market cap
1.2B
Dividend yield
-
Volume
611,427
Avg. volume
557,551
P/E ratio
-33.10